# FDA Inspection 1026928 - Vitalant - September 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/60028201-eda3-4ad0-8e48-3154eb8cce9b
Source feed: FDA_Inspections

> FDA Inspection 1026928 for Vitalant on September 20, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026928
- Company Name: Vitalant
- Inspection Date: 2017-09-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1266565 - 2025-03-26](https://www.keypedia.com/records/fda_inspections/vitalant/ad1e3235-2a35-418a-a27e-92c0ee9d8e17)
- [FDA Inspection 1266565 - 2025-03-26](https://www.keypedia.com/records/fda_inspections/vitalant/98325ec6-3cfe-4859-b70e-72d5cb228d31)
- [FDA Inspection 1160555 - 2021-12-16](https://www.keypedia.com/records/fda_inspections/vitalant/b7cd253f-b21a-4696-ae8b-c2621eb900bb)
- [FDA Inspection 1160555 - 2021-12-16](https://www.keypedia.com/records/fda_inspections/vitalant/cd002ca8-30fd-4d6e-a187-7c278f076e1a)
- [FDA Inspection 942096 - 2015-09-10](https://www.keypedia.com/records/fda_inspections/vitalant/98cf4833-928f-4ac7-8b90-df2944834bb3)

Company: https://www.keypedia.com/companies/vitalant/c27a0091-d013-4498-9622-93d3698d4a34

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d